Evogenom Appoints Sofia Lund as CEO to Lead International Expansion

Jyväskylä, Finland – [November 14, 2024 10:00 AM] – Evogenom, a Finnish wellness technology company with a strong foundation in scientific expertise and research, appointed Sofia Lund as its new CEO effective November 1, 2024. Lund brings a bold vision to build Evogenom into the world’s leading consumer brand in wellness genetics, starting in Europe next year.

Initiating a New Phase of International Growth

Lund has a strong background in building and scaling biotechnology companies internationally. Previously, she led the brand development of Blueprint Genetics, helping the company become a key player in the industry before its successful acquisition. With Evogenom’s strong foundation in genetic insights and expertise, the company is well-positioned for global expansion.

“Evogenom is at the start of an exciting growth journey, and I’m thrilled to lead our expansion beyond Finland next year,” Sofia Lund states. “Our vision is to provide people with personalized wellness recommendations that empower them to make proactive choices for their health. This is the beginning of a new era in wellness, where individuals can understand and leverage their unique biology in a way that is both accessible and insightful. By combining scientific accuracy with a personal approach, we’re able to create wellness solutions that truly align with each individual’s goals and lifestyle.”

An Experienced Leader in Brand-Building

Lund played a key role in the development of Blueprint Genetics, where she led the shaping of the brand and customer experience — critical factors in the company’s success and eventual acquisition. In addition to Blueprint Genetics, Lund has supported and guided several biotechnology companies, most recently Avenue Biosciences, where she served as an advisor and brand strategist. Lund also has over 15 years of experience in consumer brand marketing, having worked with established brands such as Fiskars and L’Oréal.

Building the Future of Wellness with Data-Driven Insights, with a Focus on Quality and Scientific Validation

As Evogenom expands into international markets, Lund’s vision emphasizes a commitment to scientific accuracy and quality. “When it comes to understanding and utilizing the human genome, scientific validation is essential,” she explains. “Evogenom is committed to ensuring that all our products are based on solid, scientifically validated data. Our customers can trust that we provide innovative wellness solutions while upholding the highest standards of accuracy and reliability.”

As Evogenom grows globally, Lund envisions a future where the company’s offerings go beyond genetic testing to create a holistic wellness experience that combines personal health data with genetic insights. Evogenom believes in a future of wellness where bio-data, personalized insights, and habit change form the foundation of a healthier life. This new era empowers individuals to take charge of their health like never before, using precise, integrated information to make positive and lasting changes.
With strong connections to Finland’s top universities in genetics and sports science, Evogenom is uniquely positioned to bring research-driven, consumer-friendly wellness solutions to a global audience.

Hannu Tolvanen – Outgoing CEO

Evogenom’s outgoing CEO Hannu Tolvanen shares his enthusiasm about the company’s future under Lund’s leadership: “Sofia Lund brings a unique combination of expertise in genetics, brand development, and customer experience, which will be essential as Evogenom expands its vision. Her leadership and innovative approach are exactly what we need to move forward. I am confident that she will guide the company along the growth path we have laid out.”

Hannu Tolvanen will continue as a significant shareholder and active team member at Evogenom, supporting Sofia Lund through the transition.

About Evogenom

Evogenom is a Finnish wellness technology company with strong roots in the scientific community. The company provides genetic tests that help individuals learn more about their unique biology. Its comprehensive and accurate results support individuals in achieving their wellness goals and give new meaning to measured data from a personal health perspective.

Further information

CEO Sofia Lund, sofia.lund@evogenom.com, +358 400 849 393
COO Hannu Tolvanen, hannu.tolvanen@evogenom.com, +358 400 642 569
Marketing Manager Laura Kauppinen, laura.kauppinen@evogenom.com, +358 40 654 1104

Tags: